Market Overview

Medley's Growth Initiatives Are Already Priced Into The Stock

Share:
Related MDLY
61 Biggest Movers From Friday
Mid-Afternoon Market Update: Dow Down Over 250 Points; Medley Management Shares Spike Higher
Medley Capital Corporation's Merger Will Not Save The Company For Long (Seeking Alpha)

Ladenburg Thalmann downgraded Medley Management Inc (NYSE: MDLY) to Neutral from Buy on valuation. However, the brokerage raised its price target by $1.50 to $7.50, implying a potential return of 4 percent.

Medley reported Q2 core EPS of $0.14, which missed Ladenburg forecast/consensus of $0.16 on higher compensation and G&A expenses. Higher fee income, driven by robust leveraged loan market, mitigated declines in private funds and SMAs.

The company total AUM (committed funds) at the end of second quarter remained at $5.0 billion versus $3.2 billion invested.

"MDLY has been a strong performer since mid-1Q16 as the leveraged loan market has rebounded within a stronger credit environment," analyst Mickey Schleien wrote in a note.

However, the brokerage cut its 2016 core EPS forecast to $0.59 from $0.63 to reflect this quarter's miss, reduced FAUM growth assumptions, and higher forecast expenses. It also set a 2017 core EPS forecast of $0.69 (consensus is $0.72).

At time of writing, shares of Medley were down 0.50 percent to $7.94.

Latest Ratings for MDLY

DateFirmActionFromTo
Aug 2018Credit SuisseMaintainsNeutralNeutral
Nov 2016Deutsche BankDowngradesBuyHold
Nov 2016Ladenburg ThalmannUpgradesNeutralBuy

View More Analyst Ratings for MDLY
View the Latest Analyst Ratings

Posted-In: Ladenburg Thalmann Mickey SchleienAnalyst Color Downgrades Price Target Analyst Ratings

 

Related Articles (MDLY)

View Comments and Join the Discussion!

El-Erian's 3-Point Plan To Avoid A Recession

Technical Alert: Horrible August For Ligand Pharmaceuticals Continues